Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. [electronic resource] by
- Sohal, Jastinder
- Phan, Vernon T
- Chan, Philip V
- Davis, Elizabeth M
- Patel, Bhumi
- Kelly, Louise M
- Abrams, Tinya J
- O'Farrell, Anne Marie
- Gilliland, D Gary
- Le Beau, Michelle M
- Kogan, Scott C
Producer: 20030618
In:
Blood vol. 101
Availability: No items available.
|
|
|
10.
|
SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model. [electronic resource] by
- Murray, Lesley J
- Abrams, Tinya J
- Long, Kelly R
- Ngai, Theresa J
- Olson, Lisa M
- Hong, Weiru
- Keast, Paul K
- Brassard, Jacqueline A
- O'Farrell, Anne Marie
- Cherrington, Julie M
- Pryer, Nancy K
Producer: 20040122
In:
Clinical & experimental metastasis vol. 20
Availability: No items available.
|
|
|
11.
|
Child Health Care in Ireland. [electronic resource] by
- Staines, Anthony
- Balanda, Kevin P
- Barron, Steve
- Corcoran, Yvonne
- Fahy, Lorraine
- Gallagher, Louise
- Greally, Tessa
- Kilroe, Jean
- Mohan, Caroline Mason
- Matthews, Anne
- McGovern, Elyce
- Nicholson, Alf
- O'Farrell, Anne
- Philip, Roy K
- Whelton, Helen
Producer: 20171222
In:
The Journal of pediatrics vol. 177S
Availability: No items available.
|
|
|
12.
|
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia. [electronic resource] by
- O'Farrell, Anne-Marie
- Yuen, Helene A
- Smolich, Beverly
- Hannah, Alison L
- Louie, Sharianne G
- Hong, Weiru
- Stopeck, Alison T
- Silverman, Lewis R
- Lancet, Jeffrey E
- Karp, Judith E
- Albitar, Maher
- Cherrington, Julie M
- Giles, Francis J
Producer: 20040722
In:
Leukemia research vol. 28
Availability: No items available.
|
|
|
13.
|
A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia. [electronic resource] by
- Fiedler, Walter
- Mesters, Rolf
- Tinnefeld, Heike
- Loges, Sonja
- Staib, Peter
- Duhrsen, Ulrich
- Flasshove, Michael
- Ottmann, Oliver G
- Jung, Wolfram
- Cavalli, Franco
- Kuse, Rolf
- Thomalla, Joerg
- Serve, Hubert
- O'Farrell, Anne M
- Jacobs, Mark
- Brega, Nicoletta M
- Scigalla, Paul
- Hossfeld, Dieter K
- Berdel, Wolfgang E
Producer: 20031124
In:
Blood vol. 102
Availability: No items available.
|
|
|
14.
|
SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity. [electronic resource] by
- Patyna, Shem
- Laird, A Douglas
- Mendel, Dirk B
- O'farrell, Anne-Marie
- Liang, Chris
- Guan, Huiping
- Vojkovsky, Tomas
- Vasile, Stefan
- Wang, Xueyan
- Chen, Jeffrey
- Grazzini, Maren
- Yang, Cheng Y
- Haznedar, Joshua O
- Sukbuntherng, Juthamas
- Zhong, Wei-Zhu
- Cherrington, Julie M
- Hu-Lowe, Dana
Producer: 20061010
In:
Molecular cancer therapeutics vol. 5
Availability: No items available.
|
|
|
15.
|
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease. [electronic resource] by
- Fiedler, Walter
- Serve, Hubert
- Döhner, Hartmut
- Schwittay, Michael
- Ottmann, Oliver G
- O'Farrell, Anne-Marie
- Bello, Carlo L
- Allred, Randy
- Manning, William C
- Cherrington, Julie M
- Louie, Sharianne G
- Hong, Weiru
- Brega, Nicoletta M
- Massimini, Giorgio
- Scigalla, Paul
- Berdel, Wolfgang E
- Hossfeld, Dieter K
Producer: 20050421
In:
Blood vol. 105
Availability: No items available.
|
|
|
16.
|
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo. [electronic resource] by
- O'Farrell, Anne-Marie
- Abrams, Tinya J
- Yuen, Helene A
- Ngai, Theresa J
- Louie, Sharianne G
- Yee, Kevin W H
- Wong, Lily M
- Hong, Weiru
- Lee, Leslie B
- Town, Ajia
- Smolich, Beverly D
- Manning, William C
- Murray, Lesley J
- Heinrich, Michael C
- Cherrington, Julie M
Producer: 20030620
In:
Blood vol. 101
Availability: No items available.
|
|
|
17.
|
An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients. [electronic resource] by
- O'Farrell, Anne-Marie
- Foran, James M
- Fiedler, Walter
- Serve, Hubert
- Paquette, Ron L
- Cooper, Maureen A
- Yuen, Helene A
- Louie, Sharianne G
- Kim, Heidi
- Nicholas, Susan
- Heinrich, Michael C
- Berdel, Wolfgang E
- Bello, Carlo
- Jacobs, Mark
- Scigalla, Paul
- Manning, William C
- Kelsey, Stephen
- Cherrington, Julie M
Producer: 20040817
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 9
Availability: No items available.
|
|
|
18.
|
SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes. [electronic resource] by
- Giles, Francis J
- Stopeck, Alison T
- Silverman, Lewis R
- Lancet, Jeffrey E
- Cooper, Maureen A
- Hannah, Alison L
- Cherrington, Julie M
- O'Farrell, Anne-Marie
- Yuen, Helene A
- Louie, Sharianne G
- Hong, Weiru
- Cortes, Jorge E
- Verstovsek, Srdan
- Albitar, Maher
- O'Brien, Susan M
- Kantarjian, Hagop M
- Karp, Judith E
Producer: 20030922
In:
Blood vol. 102
Availability: No items available.
|
|
|
19.
|
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. [electronic resource] by
- Parham, Christi
- Chirica, Madaline
- Timans, Jacqueline
- Vaisberg, Elena
- Travis, Marilyn
- Cheung, Jeanne
- Pflanz, Stefan
- Zhang, Rebecca
- Singh, Komal P
- Vega, Felix
- To, Wayne
- Wagner, Janet
- O'Farrell, Anne-Marie
- McClanahan, Terrill
- Zurawski, Sandra
- Hannum, Charles
- Gorman, Daniel
- Rennick, Donna M
- Kastelein, Robert A
- de Waal Malefyt, Rene
- Moore, Kevin W
Producer: 20020612
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 168
Availability: No items available.
|